Works matching DE "IPILIMUMAB"

Results: 2451
    1
    2

    Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.

    Published in:
    OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2015.1008814
    By:
    • Eggermont, Alexander;
    • Marabelle, Aurélien;
    • Zitvogel, Laurence;
    • Buqué, Aitziber;
    • Galluzzi, Lorenzo;
    • Bloy, Norma;
    • Castoldi, Francesca;
    • Tartour, Eric;
    • Kroemer, Guido;
    • Cremer, Isabelle;
    • Galon, Jérôme;
    • Fridman, Wolf Hervé;
    • Aranda, Fernando;
    • Spisek, Radek;
    • Fucikova, Jitka
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 490, doi. 10.1159/000541250
    By:
    • LaPelusa, Michael;
    • Chamseddine, Shadi;
    • Tran Cao, Hop Sanderson;
    • Xiao, Lianchun;
    • Hasanov, Elshad;
    • Bhosale, Priya;
    • Amin, Hesham M.;
    • Mohamed, Yehia I.;
    • Gok Yavuz, Betul;
    • Sakr, Yara;
    • Xu, Li;
    • Hu, Ian;
    • Lee, Sunyoung S.;
    • Sakamuri, Divya;
    • Jindal, Sonali;
    • Nguyen, Van;
    • Curran, Michael A.;
    • Sun, Ryan;
    • Rashid, Asif;
    • Duda, Dan Gabriel
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Long-Term Survival in Patients With Advanced Melanoma.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
    By:
    • van Not, Olivier J.;
    • van den Eertwegh, Alfons J. M.;
    • Jalving, Hilde;
    • Bloem, Manja;
    • Haanen, John B.;
    • van Rijn, Rozemarijn S.;
    • Aarts, Maureen J. B.;
    • van den Berkmortel, Franchette W. P. J.;
    • Blank, Christian U.;
    • Boers-Sonderen, Marye J.;
    • de Groot J. W. B., Jan Willem;
    • Hospers, Geke A. P.;
    • Kapiteijn, Ellen;
    • Leeneman, Brenda;
    • D., Piersma;
    • Stevense-den Boer, Marion;
    • van der Veldt, Astrid A. M.;
    • Vreugdenhil G., Gerard;
    • Wouters, Michel W. J. M.;
    • Blokx, Willeke A. M.
    Publication type:
    Article
    28
    29
    30

    Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials.

    Published in:
    Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 542, doi. 10.3390/jcm7120542
    By:
    • Grassadonia, Antonino;
    • Sperduti, Isabella;
    • Vici, Patrizia;
    • Iezzi, Laura;
    • Brocco, Davide;
    • Gamucci, Teresa;
    • Pizzuti, Laura;
    • Maugeri-Saccà, Marcello;
    • Marchetti, Paolo;
    • Cognetti, Gaetana;
    • De Tursi, Michele;
    • Natoli, Clara;
    • Barba, Maddalena;
    • Tinari, Nicola
    Publication type:
    Article
    31
    32
    33
    34
    35

    Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitor.

    Published in:
    Clinical & Translational Immunology, 2022, v. 11, n. 11, p. 1, doi. 10.1002/cti2.1425
    By:
    • Ge, Tingting;
    • Phung, Amber‐Lee;
    • Jhala, Gaurang;
    • Trivedi, Prerak;
    • Principe, Nicola;
    • De George, David J;
    • Pappas, Evan G;
    • Litwak, Sara;
    • Sanz‐Villanueva, Laura;
    • Catterall, Tara;
    • Fynch, Stacey;
    • Boon, Louis;
    • Kay, Thomas W;
    • Chee, Jonathan;
    • Krishnamurthy, Balasubramanian;
    • Thomas, Helen E
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50